A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Conditions

• Advanced Solid Tumor
• High Grade Serous Adenocarcinoma of Ovary
• Squamous Non-small-cell Lung Cancer
• Triple Negative Breast Cancer
• Head and Neck Squamous Cell Carcinoma
• Ovarian Carcinosarcoma
• Uterine Carcinosarcoma
• Uterine Serous Carcinoma
• Endometrium Cancer
• Chromosomal Instability

Interventions

• DRUG: VLS-1488

Sponsor

Volastra Therapeutics, Inc.